Noninvasive prenatal testing: the importance of pretest trisomy risk and posttest predictive values

Am J Obstet Gynecol. 2015 Apr;212(4):548-9. doi: 10.1016/j.ajog.2014.12.033. Epub 2014 Dec 30.

Authors

Joseph R Wax¹, Renee Chard², Angelina Cartin², Christian Litton², Michael G Pinette², F Lee Lucas³

Affiliations

¹ Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Maine Medical Center, Portland, ME. Electronic address: waxj@mmc.org.
² Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Maine Medical Center, Portland, ME.
³ Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME.

PMID: 25555658
DOI: 10.1016/j.ajog.2014.12.033

No abstract available

Publication types

Evaluation Study
Letter

MeSH terms

Chromosome Disorders / diagnosis
Chromosomes, Human, Pair 13
Chromosomes, Human, Pair 18
Down Syndrome / diagnosis
False Positive Reactions
Female
Genetic Testing*
Humans
Maternal Serum Screening Tests*
Predictive Value of Tests
Pregnancy
Risk Assessment
Risk Factors
Trisomy / diagnosis*
Trisomy 13 Syndrome
Trisomy 18 Syndrome